It's time all clinical trial results are reported.
Patients, researchers, pharmacists, doctors and regulators everywhere will benefit from publication of clinical trial results. Wherever you are in the world please sign the petition:
Thousands of clinical trials have not reported their results; some have not even been registered.
Information on what was done and what was found in these trials could be lost forever to doctors and researchers, leading to bad treatment decisions, missed opportunities for good medicine, and trials being repeated.
All trials past and present should be registered, and the full methods and the results reported.
We call on governments, regulators and research bodies to implement measures to achieve this.
The petition has also been translated into many different languages
. If you would like to sign the petition on behalf of an organisation then please contact us. Data will be held by Sense About Science. Read our privacy policy here.
All trials registered and results reported The AllTrials campaign has published a detailed plan on how all clinical trials can be registered and all results reported. This document sets out more information about achieving a situation globally where all trials are registered and results reported. It is an achievement that will involve regulators and registries,...
Ben Goldacre talks AllTrials at Imagining the Future of Medicine 22nd April 2014 Yesterday evening the Royal Albert Hall hosted a series of talks on Imagining the Future of Medicine, hosted by Dara Ó Briain. AllTrials co-founder Dr Ben Goldacre spoke on the importance of clinical trial transparency, the history of the AllTrials campaign and how much...
Boehringer to release clinical trial data from 1998 16th April 2014 Boehringer Ingelheim has announced that it will publish anonymised data from clinical trials dating back to the start of 1998 on the accessible platform clinicalstudydatarequest.com. The pledge was made by Boehringer’s chairman Dr Andreas Barner at the company’s annual meeting yesterday. The database was...
Project Data Sphere aims to share cancer research data 11th April 2014 A number of major pharmaceutical companies have given their support to Project Data Sphere, a new research collaboration that aims to help researchers share historical clinical trial data to help research new cancer treatments. The companies involved include AstraZeneca, Bayer, Celgene, Janssen Research...
Tamiflu and Relenza study shows we need information from all clinical trials to make good decisions about medicines 10th April 2014 A review of all the clinical trial evidence for flu medications Tamiflu and Relenza has found that they are not as effective as they seemed when only some of the data was assessed. The...
New NIMH funding requirements include clinical trial reporting 9th April 2014 The National Institute of Mental Health in the USA has announced new efforts to promote efficiency, transparency, and reporting in future clinical trials. New funding announcements will require that recipients of future grants register their trials on ClinicalTrials.gov and commit to a data sharing...
Guest Post: People with rare diseases need results from all trials 7th April 2014 By Rob Pleticha is the Online Community Manager of RareConnect.org, a EURORDIS project This is a personal opinion The International Rare Diseases Research Consortium plan to have 200 new rare diseases therapies by year 2020. In Europe a disease or disorder is defined as...
Latvian translation of the AllTrials statement is now available 3rd April 2014 There is now a Latvian Translation of the AllTrials statement thanks to one of our supporters. The document sets out four levels of information in clinical trial reporting and discusses the first three in detail: knowledge that a trial has been conducted, from a clinical trials register...
Pharmaceutical company AbbVie drops its case against the EMA 3rd April 2014 We have heard that AbbVie has applied for discontinuance in its case against the EMA, which means the case is over. The court will take the case off the register in the coming weeks and each party will bear its costs. AbbVie sued...
AllTrials is an initiative of Sense About Science, Bad Science, BMJ, James Lind Initiative, the Centre for Evidence-based Medicine, PLOS, the Cochrane Collaboration and in the US Dartmouth’s Geisel School of Medicine and the Dartmouth Institute for Health Policy & Clinical Practice.
